X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

Glass Lewis Releases U.S. Proxy Voting Policies and Guidelines for the 2020 Proxy Season

Last week, Glass Lewis & Co. (Glass Lewis) released its annual U.S. and Shareholder Initiatives prox...

Read More >

California Bill Giving Attorney General Authority to Regulate and Approve or Deny Healthcare Transactions Advances to Floor Vote

On August 20, 2020, the Committee on Appropriations of the California State Assembly approved sendin...

Read More >

OSHA Penalty Increase Effective Tomorrow

The Inflation Adjustment Act requires the Department of Labor to annually adjust its civil monetary ...

Read More >

Prevailing Wage Class Action Dismissed For Failure To Allege “Public Work” Was Involved

The area of prevailing wage law, construction wage-hour law, is a niche within a niche and a very co...

Read More >

3rd Circuit Upholds Ex-Bank Employee’s Right to Avoid Arbitration of Sarbanes-Oxley Claim for Retaliatory Termination

The Third Circuit Court of Appeals recently issued an opinion upholding the right of a former bank e...

Read More >

Bay Area COVID-19 Regulations Tracker - UPDATED November #2

In an effort to slow the spread of COVID-19, California on Aug. 31 released the Blueprint for a Safe...

Read More >